PRINCIPIA BIOPHARMA INC.: cash_and_restricted_cash
| Value | {"amount": 41236000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2017-12-31) |
| Status | current |
| Entity | PRINCIPIA BIOPHARMA INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:09:16.281997+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4aaa88f3-67e2-45e5-8536-ad847657bb02
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-008448 · Open the official SEC filing →Retrieved: 2026-08-19T15:09:16.281997+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001510487/cash-and-restricted-cash/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4aaa88f3-67e2-45e5-8536-ad847657bb02
History
- supersedes {"amount": 41054000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} (evidence 0001564590-18-027481)